Filamentous Hemagglutinin Protein (FHA)

Catalog No. ABIN934427

This Native Filamentous Hemagglutinin protein is produced in Bordetella pertussis.

Quick Overview for Filamentous Hemagglutinin Protein (FHA) (ABIN934427)

Target: Filamentous Hemagglutinin (FHA)

Protein Type: Native

Origin: Human

Source: Bordetella pertussis

Application: ELISA

Purity: > 95 % pure

Product Details

Characteristics: Filamentous Hemagglutinin purified from Bordetella Pertussis
Protein Source: Bordetella Pertussis

Application Details

Application Notes: Each Investigator should determine their own optimal working dilution for specific applications.

Comment:

Custom sizes are available on request to antibodies@fitzgerald-fii.com

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.87 mg/mL

Buffer: Frozen liquid.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: -80 °C

Storage Comment: Store at -70 °C.

Target Details

Target: Filamentous Hemagglutinin (FHA)

Alternative Name: Filamentous Hemagglutinin

Target Type: Bacteria Protein

Background: Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Filamentous hemagglutinin is a 220 kDa protein associated with the bacterial surface, but also secreted in substantial amounts. Studies using FHA-deficient B. pertussis strains implicate this protein in tracheal colonization, cell adherence, and invasion of macrophages and epithelial cells by B. pertussis. FHA is a useful tool in immunoassays and whooping cough vaccination studies.
Description: Bordetella Pertussis.
Alternative Names: FHA, Bordetella Pertussis, Purified FHA

Molecular Weight: 220 kDa